Interleukin-18: Interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome

Serum IL-18/IL-10 ratio is an independent predictor of in-hospital adverse events in patients with ACS. Our study strongly endorses the notion that an imbalance between pro and anti-inflammatory forces predisposes to plaque disruption and recurrent cardiovascular events.